180 LIFE SCIENCES CORP. - Annual Financials - Equity (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

180 LIFE SCIENCES CORP. - Annual Equity (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Balance	153691.755	-127.733	0
Balance (in Shares)	1000	534.719	0
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering	0.489
Shares issued from exercise of pre-funded warrants related to Amendment to August 2023 Offering (in Shares)	257.505
Adjustment related to reverse stock split	0	0
Adjustment related to reverse stock split (in Shares)	0.014	0
Shares issued in connection with December 2024 Offering	2572.669
Shares issued in connection with December 2024 Offering (in Shares)	1200
Shares issued from exercise of warrants	2797.841
Shares issued from exercise of warrants (in Shares)	950.069
Shares issued for settlement of liabilities	0.017
Shares issued for settlement of liabilities (in Shares)	174.158
Shares issued for professional services to directors		60.624
Shares issued for professional services to directors (in Shares)	6.315	4.763
Shares issued for professional services to executive chairman		28.565
Shares issued for professional services to executive chairman (in Shares)		7.126
Issuance of April 2023 pre-funded and common warrants, net		0
Shares issued from exercise of April 2023 pre-funded warrants		0
Shares issued from exercise of April 2023 pre-funded warrants (in Shares)		61.615
Shares issued in connection with April 2023 Offering		0.002
Shares issued in connection with April 2023 Offering (in Shares)		0
Issuance of August 2023 pre-funded and common warrants, net		2459.282
Shares issued from exercise of August 2023 pre-funded warrants		0.395
Shares issued from exercise of August 2023 pre-funded warrants (in Shares)		207.814
Shares issued in connection with August 2023 Offering		0
Shares issued in connection with August 2023 Offering (in Shares)		35.102
Issuance of pre-funded and common warrants from Amendment to August 2023 SPA, net		0
Stock based compensation	0	2194.135
Warrants and Series B Convertible Preferred Stock issued for asset acquisition	0
Reclassification of Series B Convertible Preferred Stock liability	0
Reclassification of Series B Convertible Preferred Stock liability (in Shares)	0
Deemed dividend from warrant inducement	-8011.51
Net loss	0	0
Other comprehensive loss	0	-15.816
Balance	153691.755	-127.733	0
Balance (in Shares)	1000	534.719	0